RLAY — RELAY THERAPEUTICS INC

Ownership history in Persistent Asset Partners Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which Persistent Asset Partners Ltd reported a position in RELAY THERAPEUTICS INC (RLAY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.54% (2024 Q4)
Avg. % of fund
0.17%
First filed
2024 Q4
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 10,280 — 0% 0.04% $54K $5.22
2025 Q2 REDUCED 10,280 -90,204 -89.8% 0.03% $36K $3.46
2025 Q1 ADDED 100,484 +100,181 +33063.0% 0.22% $263K $2.62
2024 Q4 REDUCED 303 -145,525 -99.8% 0.02% $24K $4.12
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RLAY price (monthly, adj. close)

Other funds also holding RLAY

As of 2025 Q4 — sorted by position size

Commodore Capital LP 3Y 9.57% Casdin Capital, LLC 3Y 7Y 6.83% Foresite Capital Management IV, LLC 3Y 7Y 3.68% SB INVESTMENT ADVISERS (UK) LTD 3Y 7Y 2.36% MPM BioImpact LLC 3Y 2.16% Elmind Capital, LP 1.34% Bellevue Group AG 3Y 7Y 1.34% HighVista Strategies LLC 3Y 7Y 1.19% TCG Crossover Management, LLC 3Y 0.9% Kynam Capital Management, LP 3Y 0.77%
← Back to Persistent Asset Partners Ltd Holdings